These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35214002)

  • 41. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
    Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
    Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystallization Risk Assessment of Amorphous Solid Dispersions by Physical Shelf-Life Modeling: A Practical Approach.
    Liu B; Theil F; Lehmkemper K; Gessner D; Li Y; van Lishaut H
    Mol Pharm; 2021 Jun; 18(6):2428-2437. PubMed ID: 34032433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.
    Boel E; Smeets A; Vergaelen M; De la Rosa VR; Hoogenboom R; Van den Mooter G
    Eur J Pharm Biopharm; 2019 Nov; 144():79-90. PubMed ID: 31499162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gaining Insight into the Role of the Solvent during Spray Drying of Amorphous Solid Dispersions by Studying Evaporation Kinetics.
    Dedroog S; Adriaensens P; Van den Mooter G
    Mol Pharm; 2022 May; 19(5):1604-1618. PubMed ID: 35362988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization.
    Moseson DE; Corum ID; Lust A; Altman KJ; Hiew TN; Eren A; Nagy ZK; Taylor LS
    AAPS J; 2021 May; 23(4):69. PubMed ID: 34002256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.
    Li N; Cape JL; Mankani BR; Zemlyanov DY; Shepard KB; Morgen MM; Taylor LS
    Mol Pharm; 2020 Oct; 17(10):4004-4017. PubMed ID: 32931293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemically identical but physically different: A comparison of spray drying, hot melt extrusion and cryo-milling for the formulation of high drug loaded amorphous solid dispersions of naproxen.
    Dedroog S; Huygens C; Van den Mooter G
    Eur J Pharm Biopharm; 2019 Feb; 135():1-12. PubMed ID: 30529295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amorphous-Amorphous Phase Separation in API/Polymer Formulations.
    Luebbert C; Huxoll F; Sadowski G
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28212300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies.
    Bhujbal SV; Mitra B; Jain U; Gong Y; Agrawal A; Karki S; Taylor LS; Kumar S; Tony Zhou Q
    Acta Pharm Sin B; 2021 Aug; 11(8):2505-2536. PubMed ID: 34522596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase behavior of ASDs based on hydroxypropyl cellulose.
    Luebbert C; Stoyanov E; Sadowski G
    Int J Pharm X; 2021 Dec; 3():100070. PubMed ID: 33409486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of polymer excipients on the dissolution and recrystallization behavior of ketoconazole: Application, variation and practical aspects of a pH shift method.
    Ullrich A; Schiffter HA
    Eur J Pharm Biopharm; 2018 Dec; 133():20-30. PubMed ID: 30261267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
    Bochmann ES; Neumann D; Gryczke A; Wagner KG
    Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isothermal microcalorimetry to investigate the phase separation for amorphous solid dispersions of AMG 517 with HPMC-AS.
    Calahan JL; Zanon RL; Alvarez-Nunez F; Munson EJ
    Mol Pharm; 2013 May; 10(5):1949-57. PubMed ID: 23574401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Compression of amorphous solid dispersions prepared by hot-melt extrusion, spray drying and vacuum drum drying.
    Schönfeld BV; Westedt U; Wagner KG
    Int J Pharm X; 2021 Dec; 3():100102. PubMed ID: 34877525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting the Solubility Advantage of Amorphous Pharmaceuticals: A Novel Thermodynamic Approach.
    Paus R; Ji Y; Vahle L; Sadowski G
    Mol Pharm; 2015 Aug; 12(8):2823-33. PubMed ID: 26107071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.